Momentum Life Sciences (“Momentum” or the “Company”), a leading commercialization platform offering patient- and provider-facing solutions that support initiation and adherence for specialty therapies, announced a strategic investment from Parthenon Capital, a growth-oriented private equity firm with a long history of supporting innovative companies in healthcare solutions and technology. The investment will provide Momentum with strategic resources and capital to accelerate its growth strategy and pursue strategic acquisitions that support the Company’s mission to address one of the most persistent challenges facing pharmaceutical and biotechnology manufacturers, patients, and providers: enabling patients to start and stay on the specialty therapies they need.
Read the full article: Momentum Life Sciences Announces Strategic Growth Investment from Parthenon Capital //
Source: https://www.parthenoncapital.com/news/momentum-life-sciences-announces-strategic-growth-investment-from-parthenon-capital/